Literature DB >> 16627595

Androgen receptor ligand-binding domain interaction and nuclear receptor specificity of FXXLF and LXXLL motifs as determined by L/F swapping.

Hendrikus J Dubbink1, Remko Hersmus, Ashley C W Pike, Michel Molier, Albert O Brinkmann, Guido Jenster, Jan Trapman.   

Abstract

The androgen receptor (AR) ligand-binding domain (LBD) binds FXXLF motifs, present in the AR N-terminal domain and AR-specific cofactors, and some LXXLL motifs of nuclear receptor coactivators. We demonstrated that in the context of the AR FXXLF motif many different amino acid residues at positions +2 and +3 are compatible with strong AR LBD interaction, although a preference for E at +2 and K or R at +3 was found. Pairwise systematic analysis of F/L swaps at +1 and +5 in FXXLF and LXXLL motifs showed: 1) F to L substitutions in natural FXXLF motifs abolished AR LBD interaction; 2) binding of interacting LXXLL motifs was unchanged or increased upon L to F substitutions; 3) certain noninteracting LXXLL motifs became strongly AR-interacting FXXLF motifs; whereas 4) other nonbinders remained unaffected by L to F substitutions. All FXXLF motifs, but not the corresponding LXXLL motifs, displayed a strong preference for AR LBD. Progesterone receptor LBD interacted with some FXXLF motifs, albeit always less efficiently than corresponding LXXLL motifs. AR LBD interaction of most FXXLF and LXXLL peptides depended on classical charge clamp residue K720, whereas E897 was less important. Other charged residues lining the AR coactivator-binding groove, K717 and R726, modulated optimal peptide binding. Interestingly, these four charged residues affected binding of individual peptides independent of an F or L at +1 and +5 in swap experiments. In conclusion, F residues determine strong and selective peptide interactions with AR. Sequences flanking the core motif determine the specific mode of FXXLF and LXXLL interactions.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16627595     DOI: 10.1210/me.2005-0348

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  19 in total

Review 1.  Steroid receptor/coactivator binding inhibitors: An update.

Authors:  Kornelia J Skowron; Kenneth Booker; Changfeng Cheng; Simone Creed; Brian P David; Phillip R Lazzara; Amy Lian; Zamia Siddiqui; Thomas E Speltz; Terry W Moore
Journal:  Mol Cell Endocrinol       Date:  2019-06-01       Impact factor: 4.102

2.  Systematic structure-function analysis of androgen receptor Leu701 mutants explains the properties of the prostate cancer mutant L701H.

Authors:  Dennis J van de Wijngaart; Michel Molier; Scott J Lusher; Remko Hersmus; Guido Jenster; Jan Trapman; Hendrikus J Dubbink
Journal:  J Biol Chem       Date:  2009-12-10       Impact factor: 5.157

3.  Identification of SRC3/AIB1 as a preferred coactivator for hormone-activated androgen receptor.

Authors:  X Edward Zhou; Kelly M Suino-Powell; Jun Li; Yuanzheng He; Jeffrey P Mackeigan; Karsten Melcher; Eu-Leong Yong; H Eric Xu
Journal:  J Biol Chem       Date:  2010-01-19       Impact factor: 5.157

4.  Identification of a new androgen receptor (AR) co-regulator BUD31 and related peptides to suppress wild-type and mutated AR-mediated prostate cancer growth via peptide screening and X-ray structure analysis.

Authors:  Cheng-Lung Hsu; Jai-Shin Liu; Po-Long Wu; Hong-Hsiang Guan; Yuh-Ling Chen; An-Chi Lin; Huei-Ju Ting; See-Tong Pang; Shauh-Der Yeh; Wen-Lung Ma; Chung-Jung Chen; Wen-Guey Wu; Chawnshang Chang
Journal:  Mol Oncol       Date:  2014-06-24       Impact factor: 6.603

5.  Functional screening of FxxLF-like peptide motifs identifies SMARCD1/BAF60a as an androgen receptor cofactor that modulates TMPRSS2 expression.

Authors:  Dennis J van de Wijngaart; Hendrikus J Dubbink; Michel Molier; Carola de Vos; Jan Trapman; Guido Jenster
Journal:  Mol Endocrinol       Date:  2009-09-17

6.  Multiple binding modes between HNF4alpha and the LXXLL motifs of PGC-1alpha lead to full activation.

Authors:  Geun Bae Rha; Guangteng Wu; Steven E Shoelson; Young-In Chi
Journal:  J Biol Chem       Date:  2009-10-21       Impact factor: 5.157

7.  Acid ceramidase (ASAH1) represses steroidogenic factor 1-dependent gene transcription in H295R human adrenocortical cells by binding to the receptor.

Authors:  Natasha C Lucki; Donghui Li; Sibali Bandyopadhyay; Elaine Wang; Alfred H Merrill; Marion B Sewer
Journal:  Mol Cell Biol       Date:  2012-08-27       Impact factor: 4.272

8.  Antagonizing the Androgen Receptor with a Biomimetic Acyltransferase.

Authors:  Yuchen Zhang; Pavan K Mantravadi; Soma Jobbagy; Wei Bao; John T Koh
Journal:  ACS Chem Biol       Date:  2016-08-26       Impact factor: 5.100

9.  Assays to Interrogate the Ability of Compounds to Inhibit the AF-2 or AF-1 Transactivation Domains of the Androgen Receptor.

Authors:  Ashley T Fancher; Yun Hua; Christopher J Strock; Paul A Johnston
Journal:  Assay Drug Dev Technol       Date:  2019-09-06       Impact factor: 1.738

10.  Structural Insights of Transcriptionally Active, Full-Length Androgen Receptor Coactivator Complexes.

Authors:  Xinzhe Yu; Ping Yi; Ross A Hamilton; Hong Shen; Muyuan Chen; Charles E Foulds; Michael A Mancini; Steven J Ludtke; Zhao Wang; Bert W O'Malley
Journal:  Mol Cell       Date:  2020-07-14       Impact factor: 17.970

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.